Latest Histopathology Stories
TauRx Publishes Positive Results of Phase II Clinical Trial in the Journal of Alzheimer's Disease ABERDEEN, Scotland and SINGAPORE, Jan.
--Funds Will Advance Breakthrough Drug Candidate NPT088 into the Clinic-- CAMBRIDGE, Mass., Jan.
Cambridge Laboratory Will Serve as Primary Location for Processing ProMark(TM), the Company's Newly-Launched Prostate Cancer Prognostic Test CAMBRIDGE, Mass., Dec.
DALLAS, December 6, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014" therapeutic market research
CAMBRIDGE, Mass., Nov.
WALNUT CREEK, Calif., Nov.
OWINGS MILLS, Md., Oct.
New Study Shows Link between Plaques and Tangles/Could Open Door to Therapeutic Target Boston (PRWEB) October 13, 2014 In what is being hailed by scientists
ProMark(TM) Validated to Predict Disease Aggressiveness and Empower Informed Treatment Decisions CAMBRIDGE, Mass., Oct.
- Webcast to Begin at 12:00 p.m.
- The word or words serving to define another word or expression, as in a dictionary entry.